secwatch.observer — SEC 8-K summary
======================================

Issuer:     NewAmsterdam Pharma Co N.V. (NAMS)
CIK:        0001936258
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0000950170-25-112345
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NewAmsterdam Pharma posts updated corporate investor presentation on Sep 2, 2025
--------------------------------------------------------------------------------

- Presentation posted on company website and furnished as an exhibit to the Form 8-K.
- Filing provides no specific financial results, pipeline updates, or material changes.
- Content of the presentation was not reproduced in the 8-K filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1936258/000095017025112345/0000950170-25-112345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1936258/000095017025112345/nams-20250902.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-112345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer